# Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis

> **NCT06354023** · PHASE2 · SUSPENDED · sponsor: **John Sledge** · enrollment: 23 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Recombinant human growth hormone

## Key facts

- **NCT ID:** NCT06354023
- **Lead sponsor:** John Sledge
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-02-08
- **Primary completion:** 2026-02-08
- **Final completion:** 2026-02-08
- **Target enrollment:** 23 (ESTIMATED)
- **Why stopped:** The study has been placed on a clinical hold by the FDA.
- **Last updated:** 2024-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06354023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06354023, "Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06354023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*